MARTINA PENAZZATO, MD, DTMH, MSC, PHD is the paediatric focal point for the HIV Department of WHO Headquarter in Geneva. She is an infectious diseases specialist with strong interest for HIV, tuberculosis and related diseases.
Her research interest, which she has developed working with the PENTA foundation, has focused on the optimization of diagnosis and treatment of HIV-infected infants and young children. In her work for the WHO, in addition to providing a major contribution to several Guidelines development processes, she has set up surveillance projects to asses HIVDR in HIV-infected infants and provided technical assistance to several countries in the African region.
In her current role she leads the work of WHO on paediatric ARV drug optimization and as part of that she contributes to a number of global initiatives to improve access to optimal drug and formulations for children. She is also leading the normative work on infant diagnosis and currently co-chair of the child survival working group for the IATT.